Table of Contents
Conference Papers in Medicine
Volume 2013 (2013), Article ID 962349, 6 pages
http://dx.doi.org/10.1155/2013/962349
Conference Paper

Androtherm Application for the Peyronie's Disease

1Centro Medico Demetra, Via Staderini 19, 05100 Terni, Italy
2Department of Biotechnics, St Istvan University, Pater K. u. 1., Gödöllö 2100, Hungary

Received 11 January 2013; Accepted 4 April 2013

Academic Editors: M. Jackson and A. Szasz

This Conference Paper is based on a presentation given by M. Ballerini at “Conference of the International Clinical Hyperthermia Society 2012” held from 12 October 2012 to 14 October 2012 in Budapest, Hungary.

Copyright © 2013 M. Ballerini et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. Shaw, K. Puri, G. Ruiz-Deya, and W. J. G. Hellstrom, “Racial consideration in the evaluation of Peyronie's disease,” Journal of Urology A, vol. 165, no. 170, p. 687, 2001. View at Google Scholar
  2. W. J. Hellstrom, “Medical management of Peyronie's disease,” Journal of Andrology, vol. 30, no. 4, pp. 397–405, 2009. View at Publisher · View at Google Scholar
  3. B. H. Smith, “Subclinical Peyronie's disease,” American Journal of Clinical Pathology, vol. 52, pp. 385–390, 1969. View at Google Scholar
  4. E. L. Rhoden, C. Teloken, H. Y. Ting, M. L. Lucas, C. Teodósio da Ros, and C. Ary Vargas Souto, “Prevalence of Peyronie's disease in men over 50-y-old from Southern Brazil,” International Journal of Impotence Research, vol. 13, no. 5, pp. 291–293, 2001. View at Publisher · View at Google Scholar · View at Scopus
  5. U. Schwarzer, F. Sommer, T. Klotz, M. Braun, B. Reifenrath, and U. Engelmann, “The prevalence of Peyronie's disease: results of a large survey,” BJU International, vol. 88, no. 7, pp. 727–730, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. E. L. Rhoden, C. Teloken, H. Y. Ting, M. L. Lucas, C. Teodósio da Ros, and C. Ary Vargas Souto, “Prevalence of Peyronie's disease in men over 50 years old,” Journal of Urology, vol. 165, p. 200, 2001. View at Google Scholar
  7. U. Schwarzer, T. Klotz, M. Braun, G. Wassmer, and U. Englemann, “Prevalence of Peyronie's disease: results of an 8,000 men survey,” Journal of Urology, vol. 163, p. 167, 2000. View at Google Scholar
  8. J. P. Mulhall, J. Schiff, and P. Guhring, “An analysis of the natural history of Peyronie's disease,” Journal of Urology, vol. 175, no. 6, pp. 21115–21117, 2006. View at Google Scholar
  9. A. Casabé, A. Bechara, G. Cheliz, W. De Bonis, and H. Rey, “Risk factors of Peyronie's disease. What does our clinical experience show?” Journal of Sexual Medicine, vol. 8, no. 2, pp. 518–523, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Stewart, M. Malto, L. Sandberg, and K. K. Colburn, “Increased serum levels of anti-elastin antibodies in patients with Peyronie's disease,” Journal of Urology, vol. 152, no. 1, pp. 105–106, 1994. View at Google Scholar · View at Scopus
  11. R. Rompel, W. Weidner, and G. Mueller-Eckhardt, “HLA association of idiopathic Peyronie's disease: an indication of autoimmune phenomena in etiopathogenesis?” Tissue Antigens, vol. 38, no. 3, pp. 104–106, 1991. View at Google Scholar · View at Scopus
  12. C. J. Devine, K. D. Somers, and L. E. Ladaga, “Peyronie's disease: pathophysiology,” Progress in Clinical and Biological Research, vol. 370, pp. 355–358, 1991. View at Google Scholar
  13. N. F. Gonzalez-Cadavid and J. Rajfer, “Mechanisms of disease: new insights into the cellular and molecular pathology of Peyronie's disease,” Nature Reviews Urology, vol. 2, pp. 291–297, 2005. View at Publisher · View at Google Scholar
  14. T. F. Lue, “Peyronie's disease: an anatomically-based hypothesis and beyond,” International Journal of Impotence Research, vol. 14, no. 5, pp. 411–413, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. W. J. G. Hellstrom and M. F. Usta, “Surgical approaches for advanced Peyronie's disease patients,” International Journal of Impotence Research, vol. 15, supplement 5, pp. S121–S124, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. J.-K. Ryu and J.-K. Suh, “Peyronie's disease: current medical treatment and future perspectives,” Korean Journal of Urology, vol. 50, no. 6, pp. 527–533, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. L. A. Levine, Peyronie's Disease: Guide to Clinical Management (Current Clinical Urology), Humana Press, New York, NY, USA, 2006.
  18. R. Wellman, Peyronie's Disease Natural Treatments and Cures, Create Spaces, New York, NY, USA, 2010.
  19. P. Singh and H. I. Maibach, “Transdermal iontophoresis. Pharmacokinetic considerations,” Clinical Pharmacokinetics, vol. 26, no. 5, pp. 327–334, 1994. View at Google Scholar · View at Scopus
  20. F. Montorsi, A. Salonia, G. Guazzoni et al., “Transdermal electromotive multi-drug administration for Peyronie's disease: preliminary results,” Journal of Andrology, vol. 21, no. 1, pp. 85–90, 2000. View at Google Scholar · View at Scopus
  21. S. M. Di Stasi, A. Giannantoni, G. Capelli et al., “Transdermal electromotive administration of verapamil and dexamethasone for Peyronie's disease,” BJU International, vol. 91, no. 9, pp. 825–829, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. S. M. Di Stasi, A. Giannantoni, R. L. Stephen et al., “A prospective, randomized study using transdermal electromotive administration of verapamil and dexamethasone for Peyronie's disease,” Journal of Urology, vol. 171, no. 4, pp. 1605–1608, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. L. A. Levine, “Treatment of Peyronie's disease with intralesional Verapamil,” Journal of Urology, vol. 169, no. 4, pp. 1775–1778, 2003. View at Google Scholar
  24. A. J. Schaeffer and A. L. Burnett, “Non-surgical intervention for Peyronie's disease,” Journal of Andrology, 2011. View at Google Scholar
  25. G. Perugia, M. Liberti, P. Vicini, F. Colistro, and V. Gentile, “Role of hyperthermia in the treatment of Peyronie's disease: a preliminary study,” International Journal of Hyperthermia, vol. 21, no. 4, pp. 367–374, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. C. C. Cusmanich, Treatment of Peyronie's Disease with Hyperthermia, Vitamin D and Testosterone: A Pilot Randomized Controlled Trial, Running Status, Ethics approval: Ethic committee of Hospital de Clinicas da Universidade Federal do Parana (Brazil), Curitiba, Brazil, 2007.
  27. V. Gentile and R. Lucera, “Infiammazione e fattori di crescita: aspetti connettivali e cellulari,” in Induratio Penis Plastica: Stato Dell'arte, pp. 49–53, Piccin Editore, Padova, Italy, 1999. View at Google Scholar
  28. D. Vernet, G. Nolazco, L. Cantini et al., “Evidence that osteogenic progenitor cells in the human tunica albuginea may originate from stem cells: implications for peyronie disease,” Biology of Reproduction, vol. 73, no. 6, pp. 1199–1210, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. S. Totan, A. Echo, and E. Yuksel, “Heat shock proteins modulate keloid fornation,” Eplasty, vol. 11, p. e21, 2011. View at Google Scholar
  30. L. X. de Young, A. J. Bella, D. B. O'Gorman, B. S. Gan, K. M. Lim, and G. B. Brock, “Protein biomarker analysis of primary Peyronie's disease cells,” Journal of Sexual Medicine, vol. 7, no. 1, part 1, pp. 99–106, 2010. View at Google Scholar
  31. G. Cavallini, “Towards an evidence-based under standing of Peyronie's disease,” International Journal of STD & AIDS, vol. 16, no. 3, pp. 187–194, 2005. View at Publisher · View at Google Scholar
  32. S. K. Yang, B. Kim, C. K. Lee et al., “Differential expression of protein related with penile apoptosis in rat after cavernous nerve resection,” Korean Journal of Andrology, vol. 29, no. 2, pp. 11–126, 2011. View at Google Scholar
  33. C. Loreto, G. Barbagli, R. Djinovic et al., “Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and its death receptor (DR5) in Peyronie's disease. A biomolecular study of apoptosis activation,” Journal of Sexual Medicine, vol. 8, no. 1, pp. 109–115, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. H. M. Nugteren, J. M. Nijman, I. J. De Jong, and M. F. Van Driel, “The association between Peyronie's and Dupuytren's disease,” International Journal of Impotence Research, vol. 23, no. 4, pp. 142–145, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. M. Khashan, P. J. Smitham, W. S. Khan, and N. J. Goddard, “Dupuytren's disease: review of the current literature,” The Open Orthopaedics Journal, vol. 5, supplement 2, pp. 283–288, 2011. View at Publisher · View at Google Scholar
  36. A. Qian, R. A. Meals, J. Rajfer, and N. F. Gonzalez-Cadavid, “Comparison of gene expression profiles between Peyronie's disease and Dupuytren's contracture,” Urology, vol. 64, no. 2, pp. 399–404, 2004. View at Publisher · View at Google Scholar · View at Scopus
  37. B. Jemec, A. O. Grobbelaar, G. D. Wilson, P. J. Smith, R. Sanders, and D. A. McGrouther, “Is dupuytren's disease caused by an imbalance between proliferation and cell death?” Journal of Hand Surgery, vol. 24, no. 5, pp. 511–514, 1999. View at Publisher · View at Google Scholar · View at Scopus
  38. S. Rehman, R. Goodacre, P. J. Day, A. Bayat, and H. V. Westerhoff, “Dupuytren's: a systems biology disease,” Arthritis Research & Therapy, vol. 13, no. 5, pp. 238–249, 2011. View at Google Scholar
  39. L. Vi, L. Feng, R. D. Zhu et al., “Periostin differentially induces proliferation, contraction and apoptosis of primary Dupuytren's disease and adjacent palmar fascia cells,” Experimental Cell Research, vol. 315, no. 20, pp. 3574–3586, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. A. Szasz, N. Szazs, and O. Szazs, Onchothermia-Principies and Prospectives, Springer science, Heidelberg, Germany, 2010.
  41. G. Andocs, O. Szasz, and A. Szasz, “Oncothermia treatment of cancer: from the laboratory to clinic,” Electromagnetic Biology and Medicine, vol. 28, no. 2, pp. 148–165, 2009. View at Publisher · View at Google Scholar · View at Scopus
  42. A. Szasz, O. Szasz, and N. Szasz, “Electro-hyperthermia: a new paradigm in cancer therapy,” Deutsche Zeitschrift fur Onkologie, vol. 33, no. 3, pp. 91–99, 2001. View at Publisher · View at Google Scholar · View at Scopus
  43. A. Szasz, “Onchothermie, OM & Ernahrung. Fachinformation,” 2008, 123:F22-F23. View at Google Scholar
  44. A. Szasz, “Onchothern, traditionen und Reformen in der onkologischen Hyperthermie,” Forun Hyperthermie. Forum Medizine, vol. 1, pp. 22–23, 2008. View at Google Scholar
  45. A. Szasz and G. Vincze, “Dose concept of oncological hyperthermia: heat-equation considering the cell destruction,” Journal of Cancer Research and Therapeutics, vol. 2, no. 4, pp. 171–181, 2006. View at Google Scholar · View at Scopus
  46. G. Fiorentini and A. Szasz, “Hyperthermia today: electric energy, a new opportunity in cancer treatment,” Journal of Cancer Research and Therapeutics, vol. 2, no. 2, pp. 41–46, 2006. View at Google Scholar · View at Scopus
  47. A. Szasz, “Elektromagnetische Hyperthermieverfaharen: die kapazitive kopplung, forum komplementare onkologie,” Hyperthermie, vol. 4, pp. 3–9, 2003. View at Google Scholar